What are the guidelines for managing diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guidelines for Managing Diabetes

The management of diabetes should begin with metformin plus lifestyle modifications, followed by the addition of SGLT-2 inhibitors or GLP-1 receptor agonists, especially in patients with cardiovascular or renal comorbidities. 1

Comprehensive Approach to Diabetes Management

Initial Evaluation and Diagnosis

  • Complete medical evaluation to classify diabetes, detect complications, and formulate management plan 2
  • Laboratory tests to evaluate glycemic control (HbA1c), renal function, lipid profile
  • Screen for autoimmune diseases in type 1 diabetes (thyroid dysfunction, celiac disease) 2
  • Assess for comorbidities including cardiovascular disease, hypertension, dyslipidemia, and obesity

Treatment Goals

  • Target HbA1c <7% for most adults 1
  • More stringent targets (<6.5%) for patients with short disease duration and long life expectancy
  • Less stringent targets (<8%) for those with history of severe hypoglycemia or advanced complications
  • Monitor HbA1c every 3-6 months to assess medication adherence and adjust therapy 1

Medication Management

First-Line Therapy

  • Metformin is the preferred initial pharmacologic agent for type 2 diabetes 2, 1
  • Start at diagnosis unless contraindicated
  • Contraindications include eGFR <30 ml/min/1.73m², active liver disease, or risk of lactic acidosis

Second-Line Therapy (Based on Comorbidities)

  • For patients with heart failure or chronic kidney disease: Add SGLT-2 inhibitors 1
  • For patients with increased stroke risk or weight loss goals: Add GLP-1 receptor agonists 1
  • When adding these medications results in adequate glycemic control, reduce or discontinue sulfonylureas or long-acting insulins to decrease hypoglycemia risk 1

Insulin Therapy

  • Consider for patients with severe hyperglycemia (A1C ≥10-12%, blood glucose ≥300-350 mg/dL)
  • Begin with basal insulin (0.1-0.2 units/kg/day) 1
  • Adjust based on blood glucose monitoring results

Lifestyle Management

Nutrition Therapy

  • Individualized medical nutrition therapy program, preferably provided by a registered dietitian 2
  • Diet high in vegetables, fruits, whole grains, fiber, legumes, plant-based proteins, unsaturated fats, and nuts 1
  • Reduce intake of processed meats, refined carbohydrates, and sweetened beverages 1
  • Protein intake of 0.8 g/kg/day for patients not on dialysis 1
  • Sodium intake less than 2g per day 1
  • Target initial weight loss of 7% of baseline weight 1

Physical Activity

  • At least 150 minutes of moderate-intensity aerobic activity per week 2, 1
  • Resistance training at least twice per week 2, 3
  • Reduce sedentary time with frequent activity breaks 3
  • Consider afternoon or post-meal exercise for better glycemic benefits 4

Self-Management Education

  • All patients should participate in diabetes self-management education and support 2
  • Focus on problem-solving skills for all aspects of diabetes management 2
  • Structured educational program to empower patients 1

Special Considerations

Hypoglycemia Management

  • Hypoglycemia (plasma glucose <70 mg/dL) is a major limiting factor in glycemic management 2
  • Treat with 15-20g of rapid-acting glucose and confirm reversal with blood glucose monitoring after 15 minutes 2
  • For patients with hypoglycemia unawareness, consider increasing glycemic targets temporarily 2
  • Prescribe glucagon for patients at risk for severe hypoglycemia 2

Cardiovascular and Renal Protection

  • Use ACE inhibitors or ARBs for patients with hypertension and albuminuria 1
  • Statin therapy recommended for all patients with diabetes 1
  • SGLT2 inhibitors provide kidney protection and should be prioritized 1
  • Adjust medication doses based on eGFR and monitor renal function regularly 1

Team-Based Care

  • Patients should receive care from a collaborative, interdisciplinary team 2
  • Team may include physicians, nurse practitioners, physician assistants, nurses, dietitians, exercise specialists, pharmacists, dentists, podiatrists, and mental health professionals 2
  • Use patient-centered communication that elicits patient preferences and assesses potential barriers to care 2

Common Pitfalls and How to Avoid Them

  1. Therapeutic Inertia: Regularly assess treatment efficacy and intensify therapy when needed to avoid clinical inertia 2

  2. Hypoglycemia Risk: When adding medications that improve glycemic control, reduce doses of sulfonylureas or insulin to prevent hypoglycemia 1

  3. Medication Side Effects: Monitor for side effects of medications, particularly:

    • Metformin: GI side effects, vitamin B12 deficiency
    • SGLT-2 inhibitors: Genital infections, volume depletion, diabetic ketoacidosis
    • GLP-1 receptor agonists: Nausea, vomiting, pancreatitis
  4. Overlooking Comorbidities: Regularly screen for and manage diabetes-related complications including retinopathy, nephropathy, neuropathy, and cardiovascular disease 2

  5. Inadequate Self-Management Support: Ensure patients have the knowledge and tools needed for effective self-management, including blood glucose monitoring, medication administration, and recognition of hypo/hyperglycemia 2

By following these comprehensive guidelines, healthcare providers can optimize diabetes management, reduce complications, and improve quality of life for patients with diabetes.

References

Guideline

Type 2 Diabetes Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The importance of exercise for glycemic control in type 2 diabetes.

American journal of medicine open, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.